DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients.

Yuan, Xiao-Qing; Peng, Li; Zeng, Wen-Jing; Jiang, Bin-Yuan; Li, Guan-Cheng; Chen, Xiao-Ping

Yuan, Xiao-Qing; Peng, Li; Zeng, Wen-Jing; Jiang, Bin-Yuan; Li, Guan-Cheng; Chen, Xiao-Ping.

Afiliação

Yuan XQ; From the Department of Clinical Pharmacology, Xiangya Hospital; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics (X-QY, W-JZ, X-PC); Cancer Research Institute, Central South University; Key Laboratory of Carcinogenesis, National Health and Family Planning Commission; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Changsha (LP, B-YJ, G-CL); and Hunan Province Cooperation Innovation Center for Molecular Target New

Medicine (Baltimore) ; 95(18): e3519, 2016 May.

Article em En | MEDLINE | ID: mdl-27149454

Assuntos

DNA (Citosina-5-)-Metiltransferases/genética; Leucemia Mieloide Aguda; DNA Metiltransferase 3A; Humanos; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/genética; Prognóstico; Análise de Sobrevida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / DNA (Citosina-5-)-Metiltransferases Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google